Cargando…
Circulating NPTX2 methylation as a non-invasive biomarker for prognosis and monitoring of metastatic pancreatic cancer
BACKGROUND: Pancreatic cancer is the most lethal cancer with a dismal prognosis mainly due to diagnosis at advanced stage and ineffective treatments. CA19-9 levels and computed tomography (CT) imaging are the main standard criteria for evaluating disease progression and treatment response. In this s...
Autores principales: | García-Ortiz, María Victoria, Cano-Ramírez, Pablo, Toledano-Fonseca, Marta, Cano, María Teresa, Inga-Saavedra, Elizabeth, Rodríguez-Alonso, Rosa María, Guil-Luna, Silvia, Gómez-España, María Auxiliadora, Rodríguez-Ariza, Antonio, Aranda, Enrique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362605/ https://www.ncbi.nlm.nih.gov/pubmed/37481552 http://dx.doi.org/10.1186/s13148-023-01535-4 |
Ejemplares similares
-
Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer
por: Toledano-Fonseca, Marta, et al.
Publicado: (2020) -
The Combination of Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer
por: Toledano-Fonseca, Marta, et al.
Publicado: (2021) -
Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects
por: García-Ortiz, María Victoria, et al.
Publicado: (2023) -
Basal VEGF-A and ACE Plasma Levels of Metastatic Colorectal Cancer Patients Have Prognostic Value for First-Line Treatment with Chemotherapy Plus Bevacizumab
por: Ortiz-Morales, M. José, et al.
Publicado: (2022) -
NPTX2 and cognitive dysfunction in Alzheimer’s Disease
por: Xiao, Mei-Fang, et al.
Publicado: (2017)